FH-deficient
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Sintilimab in FH-deficient Renal Cell Carcinoma (NCT04146831) | West China Hospital | 2020-06-01 |
Track FH-deficient automatically
Every clearance here is in the API, with alerts when new ones post.